n-3 Fatty Acid Supplementation and Leukocyte Telomere Length in Patients with Chronic Kidney Disease
Anne Barden(The University of Western Australia), Trevor A. Mori(The University of Western Australia), Lawrence J. Beilin(The University of Western Australia), Ashley Irish, Emile Mas(The University of Western Australia), Rae‐Chi Huang(The Kids Research Institute Australia), Nathan J. O’Callaghan(South Australian Health and Medical Research Institute), Gerald F. Watts(Royal Perth Hospital), Michael Fenech(Wine Australia), Valerie Burke(University of Western Australia), Ian B. Puddey(St Vincent's Hospital Melbourne)
Cited by 45
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Cytokinesis-block micronucleus cytome assay
|Nature Protocols|2007|2k
Measurement of micronuclei in lymphocytes
|Mutation Research/Environmental Mutagenesis and Related Subjects|1985|1.8k
Lipoprotein(a) as a cardiovascular risk factor: current status
|European Heart Journal|2010|1.8k